|
|
|
Insider
Information: |
Essex Woodlands Ix, Llc |
Relationship: |
|
City: |
The Woodlands |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
46,037,467 |
|
Indirect Shares
|
19,828,777 |
|
|
Direct
Value |
$44,165,600 |
|
|
Indirect Value
|
$5,220,750 |
|
|
Total
Shares |
65,866,244 |
|
|
Total
Value |
$49,386,351 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
Percentage
Gain/Loss : |
-50.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Axogen Inc |
AXGN |
10% Owner |
2015-08-26 |
4,861,111 |
|
0 |
Premium* |
|
EyePoint Pharmaceuticals Inc |
EYPT |
10% Owner |
2018-06-25 |
25,470,390 |
2023-09-01 |
3,490,921 |
Premium* |
|
Venus Concept Inc |
VERO |
|
2021-12-15 |
15,705,966 |
2021-12-15 |
16,337,856 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AXGN |
Axogen Inc |
10% Owner |
|
2015-08-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,861,111 |
|
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
10% Owner |
|
2018-03-28 |
4 |
B |
$1.10 |
$366,149 |
I/I |
332,863 |
8,606,324 |
1.5 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
10% Owner |
|
2018-03-28 |
4 |
B |
$1.10 |
$9,100,807 |
D/D |
8,273,461 |
8,606,324 |
2.45 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
10% Owner |
|
2018-06-25 |
4 |
B |
$1.27 |
$825,089 |
I/I |
652,244 |
25,470,390 |
1.5 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
10% Owner |
|
2018-06-25 |
4 |
B |
$1.27 |
$20,507,955 |
D/D |
16,211,822 |
25,470,390 |
2.45 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See footnotes 1 and 2 |
|
2023-08-22 |
4 |
S |
$14.62 |
$683,834 |
I/I |
(46,778) |
4,144,143 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See footnotes 1 and 2 |
|
2023-08-23 |
4 |
S |
$13.05 |
$1,580,915 |
I/I |
(121,103) |
4,023,040 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See footnotes 1 and 2 |
|
2023-08-24 |
4 |
S |
$14.62 |
$2,036,093 |
I/I |
(139,280) |
3,883,760 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See footnotes 1 and 2 |
|
2023-08-25 |
4 |
S |
$10.67 |
$931,479 |
I/I |
(84,656) |
3,799,104 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See footnotes 1 and 4 |
|
2023-08-28 |
4 |
S |
$11.71 |
$712,653 |
I/I |
(60,858) |
3,738,246 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See footnotes 1 and 4 |
|
2023-08-29 |
4 |
S |
$10.74 |
$944,225 |
I/I |
(87,854) |
3,650,392 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See footnotes 1 and 3 |
|
2023-09-01 |
4 |
S |
$9.90 |
$197,982 |
I/I |
(20,000) |
3,490,921 |
0 |
- |
|
VERO |
Venus Concept Inc |
10% Owner |
|
2019-11-07 |
4 |
A |
$0.00 |
$5,397,889 |
D/D |
6,746,431 |
6,959,945 |
0 |
- |
|
VERO |
Venus Concept Inc |
10% Owner |
|
2019-11-07 |
4 |
A |
$0.00 |
$217,166 |
I/I |
271,425 |
7,017,856 |
0 |
- |
|
VERO |
Venus Concept Inc |
10% Owner |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
208,853 |
12,417,856 |
0 |
- |
|
VERO |
Venus Concept Inc |
10% Owner |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,191,147 |
12,209,003 |
0 |
- |
|
VERO |
Venus Concept Inc |
|
|
2021-12-15 |
4 |
B |
$1.25 |
$189,515 |
I/I |
151,612 |
16,337,856 |
0.01 |
% |
|
VERO |
Venus Concept Inc |
|
|
2021-12-15 |
4 |
B |
$1.25 |
$4,710,485 |
D/D |
3,768,388 |
15,705,966 |
0.01 |
% |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|